13F filer · CIK 895421 ↗
Morgan Stanley
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$733.72B
−4.8% on the quarter before
Positions
8,003
311 new · 330 sold out
Top 10
15.9%
of the value
Est. gain
−$38.77B
on stocks held all quarter
Est. return
−5.2%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Morgan Stanley's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 25% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF Tr~$751.5MAdded · 1.5% → 1.6%+2,104,105 shares
- Microsoft~$660.1MAdded · 3.4% → 3.3%+2,834,059 shares
- Cigna Corp New~$551.9MAdded · 0.1% → 0.2%+1,988,924 shares
- J P Morgan Exchange Traded F~$535.8MAdded · 0.2% → 0.3%+10,681,491 shares
- Select Sector SPDR Tr~$504.4MAdded · 0.2% → 0.2%+7,004,109 shares
- 3m Co~$469.9MAdded · 0.1% → 0.1%+4,252,138 shares
- Ishares Tr~$415.2MAdded · 0.1% → 0.1%+16,057,587 shares
- Invesco Qqq Tr~$406.5MAdded · 0.5% → 0.6%+1,521,067 shares
- Vanguard Malvern Fds~$393.2MAdded · 0.1% → 0.1%+8,173,416 shares
- Ishares Tr~$344.5MAdded · 0.2% → 0.3%+3,576,174 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amgen Inc~$527.9MCut · 0.4% → 0.4%−2,342,274 shares
- Bristol-Myers Squibb Co~$469.3MCut · 0.4% → 0.3%−6,600,811 shares
- Select Sector SPDR Tr~$461.1MCut · 0.2% → 0.1%−7,038,059 shares
- Zoom~$430.6MCut · 0.2% → 0.1%−5,850,961 shares
- Veeva Systems~$375.4MCut · 0.2% → 0.1%−2,276,910 shares
- Unity Software Inc~$368.4MCut · 0.1% → 0.0%−11,562,936 shares
- Icici Bank Limited~$344.2MCut · 0.1% → 0.1%−16,413,075 shares
- Gsk Plc~$339.6MSold out · 0.0% → 0.0%−7,801,625 shares
- Ishares Tr~$329.5MCut · 0.2% → 0.2%−4,057,367 shares
- Colgate Palmolive Co~$324.3MCut · 0.1% → 0.1%−4,617,084 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.2% · price +1.1% | 3.4% | $25.25B | +$270.0M | ||||||||
| MicrosoftCOM · shares +2.8% · price −9.3% | 3.3% | $24.40B | −$2.44B | ||||||||
| AmazonCOM · shares +0.03% · price +6.4% | 1.9% | $13.61B | +$817.4M | ||||||||
| SPDR S&P 500 ETF TrTR UNIT · shares +6.7% · price −5.3% | 1.6% | $11.97B | −$630.4M | ||||||||
| AlphabetCAP STK CL A · shares −0.2% · price −12.2% | 1.2% | $9.00B | −$1.25B | ||||||||
| Visa Inc.COM CL A · shares +1.5% · price −9.8% | 1.1% | $8.04B | −$858.1M | ||||||||
| Unitedhealth Group IncCOM · shares +1.8% · price −1.7% | 0.95% | $6.94B | −$115.9M | ||||||||
| Johnson & JohnsonCOM · shares −0.6% · price −8.0% | 0.84% | $6.16B | −$533.5M | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares +0.07% · price −5.4% | 0.79% | $5.82B | −$329.2M | ||||||||
| TeslaCOM · shares +6.8% · price +18.2% | 0.73% | $5.33B | +$768.2M | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.6% · price −7.2% | 0.73% | $5.33B | −$402.8M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +0.6% · price −2.2% | 0.69% | $5.08B | −$113.6M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +0.2% · price −6.6% | 0.69% | $5.05B | −$358.9M | ||||||||
| AlphabetCAP STK CL C · shares −0.8% · price −12.1% | 0.68% | $5.02B | −$689.8M | ||||||||
| Procter And Gamble CoCOM · shares −2.4% · price −12.2% | 0.68% | $4.97B | −$690.4M | ||||||||
| Ishares TrCORE S&P500 ETF · shares −0.9% · price −5.4% | 0.65% | $4.80B | −$274.3M | ||||||||
| Home Depot IncCOM · shares +3.0% · price +0.6% | 0.64% | $4.70B | +$27.6M | ||||||||
| Ishares TrRUS 1000 GRW ETF · shares −0.7% · price −3.8% | 0.60% | $4.38B | −$172.8M | ||||||||
| Danaher CorporationCOM · shares −0.3% · price +1.9% | 0.59% | $4.37B | +$80.6M | ||||||||
| UberCOM · shares −0.9% · price +29.5% | 0.59% | $4.34B | +$989.6M | ||||||||
| Chevron Corp NewCOM · shares −0.03% · price −0.8% | 0.57% | $4.19B | −$32.4M | ||||||||
| MetaCL A · shares −4.4% · price −15.9% | 0.56% | $4.14B | −$781.1M | ||||||||
| Ishares TrRUS 1000 VAL ETF · shares −1.7% · price −6.2% | 0.56% | $4.14B | −$273.3M | ||||||||
| Exxon Mobil CorpCOM · shares +7.0% · price +2.0% | 0.56% | $4.10B | +$73.2M | ||||||||
| Vanguard Bd Index FdsTOTAL BND MRKT · shares +2.3% · price −5.2% | 0.56% | $4.09B | −$220.3M | ||||||||
| Total · 8,003 positions | 100% | $733.72B | −$38.77B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 7,176 stocks held throughout, down $38.77B (−5.2%).
- Uber+$989.6M+30%
- Amazon+$817.4M+6%
- Tesla3:1 split+$768.2M+18%
- The Trade Desk+$647.5M+43%
- MercadoLibre+$558.1M+30%
- Adobe−$757.1M−25%
- Meta−$781.1M−16%
- Visa Inc.−$858.1M−10%
- Alphabet20:1 split−$1.25B−12%
- Microsoft−$2.44B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 41 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $1.89T+14% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.66T−1% | SEC ↗ |
| Q4 2025 | May 27, 2026 (amended) | $1.67T+1% | SEC ↗ |
| Q3 2025 | May 27, 2026 (amended) | $1.65T+8% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $1.54T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.40T−2% | SEC ↗ |
| Q4 2024 | May 15, 2025 (amended) | $1.43T+3% | SEC ↗ |
| Q3 2024 | May 14, 2025 (amended) | $1.38T+7% | SEC ↗ |
| Q2 2024 | May 14, 2025 (amended) | $1.29T−65% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $3.74T+65% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 (amended) | $2.27T+131% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $983.41B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.01T+9% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $932.64B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $880.47B+20% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $733.72B−5% | SEC ↗ |
| Q2 2022 | Oct 27, 2022 (amended) | $770.42B+4% | SEC ↗ |
| Q1 2022 | Oct 27, 2022 (amended) | $741.46B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $809.87B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $742.48B−2% | SEC ↗ |
| Q2 2021 | Aug 23, 2021 (amended) | $758.13B+11% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $680.76B+5% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $647.47B+25% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $517.01B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $451.78B+23% | SEC ↗ |
| Q1 2020 | May 26, 2020 (amended) | $367.99B−14% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $430.00B+14% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $377.76B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $375.74B+6% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $353.27B+6% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $334.17B−16% | SEC ↗ |
| Q3 2018 | Apr 23, 2019 (amended) | $399.53B+8% | SEC ↗ |
| Q2 2018 | Apr 23, 2019 (amended) | $370.13B+3% | SEC ↗ |
| Q1 2018 | Apr 23, 2019 (amended) | $360.30B−1% | SEC ↗ |
| Q4 2017 | Apr 23, 2019 (amended) | $365.35B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $333.86B+1% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $331.01B−49% | SEC ↗ |
| Q1 2017 | May 12, 2017 (amended) | $651.13B+7% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 (amended) | $611.12B+109% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $292.79B+6% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $276.85B+7% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $259.85B | SEC ↗ |